Form 4: Haemonetics Corp: Executive Trades Common Stock

Laurie A. Miller, SVP of Human Resources at Haemonetics Corp, reported a transaction involving common stock on June 5, 2026.

Summary

• Laurie A. Miller, Senior Vice President of Human Resources at Haemonetics Corp, engaged in a transaction involving the company's common stock on June 5, 2026.
• The transaction involved 313 shares of common stock, acquired at a price of $71.28 per share.
• These shares were withheld to cover tax obligations related to the vesting of restricted stock units (RSUs).
• Following this transaction, Ms. Miller beneficially owns 40,987 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction related to executive compensation rather than a strategic move or significant change in beneficial ownership.

Positives

• The transaction indicates the vesting of restricted stock units, which is a common form of executive compensation and can be seen as a positive sign of employee retention and incentive alignment.
• The executive continues to hold a significant number of shares (40,987) after the tax withholding, suggesting continued investment in the company.

Negatives

• The withholding of shares for tax obligations represents a reduction in the executive's direct shareholding compared to the gross amount of vested RSUs.

Risks

• While not explicitly stated as a risk in this filing, the reliance on RSU vesting for executive compensation could be subject to fluctuations in stock price, impacting the net value received by the executive.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The withholding of shares for tax obligations upon RSU vesting is a common practice across the healthcare technology sector, reflecting standard executive compensation structures.

Stakeholder Impact

• Shareholders: The transaction itself does not directly impact the company's value but provides transparency into executive compensation and ownership. The continued ownership by management can be viewed positively.
• Employees: The vesting of RSUs signifies a reward for employee performance and contributes to employee retention.
• Management: Laurie A. Miller's beneficial ownership is updated, reflecting the net shares held after tax obligations.

Next Steps

• Continued monitoring of insider transactions for any significant changes in beneficial ownership or trading patterns.

Key Dates

Keywords

Haemonetics Corp, HAE, Form 4, Insider Trading, Executive Compensation, Restricted Stock Units, RSU Vesting, Stock Transaction, Securities Ownership